Hydration and Electrolytes on GLP-1 Medication

Aug 26

4 min read

Hydration doesn't get the same attention as nausea or protein on most GLP-1 advice pages, but it deserves to — it's specifically flagged in clinical trial safety protocols as a genuine risk pathway, not just a general wellness tip.

Why dehydration happens more easily on a GLP-1

GLP-1 medications can make you less thirsty, which means dehydration can develop without you necessarily noticing it happening (GoodRx, 2026). This is compounded by two other factors: reduced overall food intake means less water coming from food sources than you're used to, and gastrointestinal side effects like nausea, vomiting, and diarrhoea can cause direct fluid loss on top of reduced intake (GoodRx, 2026; Ro, 2026).

This isn't a minor side note. Multiple official Novo Nordisk clinical trial protocols for semaglutide specifically state that gastrointestinal adverse events including nausea, vomiting, and diarrhoea may lead to significant dehydration and secondary acute kidney injury, and recommend that patients experiencing these side effects drink plenty of fluids specifically to avoid volume depletion (Novo Nordisk Trial Protocols, ClinicalTrials.gov, 2016–2024). Serum creatinine and other kidney function markers are routinely monitored throughout these trials for exactly this reason (Novo Nordisk Trial Protocols, ClinicalTrials.gov, 2016–2024).

How much water you actually need

There's no official, GLP-1-specific hydration guideline (Ro, 2026). The general reference point for adults is approximately 2.7 litres of total water daily for women and 3.7 litres for men, including water from both beverages and food (Ro, 2026). If you're losing fluids through vomiting or diarrhoea, you'll likely need more than this baseline (Ro, 2026) — and it's worth building in that buffer proactively during periods when side effects are more active, such as shortly after a dose increase.

What happens if you don't hit it

Dehydration on a GLP-1 medication isn't just uncomfortable — left unaddressed, it can lead to a chain of more serious issues:

Kidney injury. Dehydration reduces blood flow to the kidneys, which can affect kidney function directly (GoodRx, 2026) — this is precisely the mechanism flagged in the clinical trial protocols above.
Dizziness, lightheadedness, and fainting, driven by reduced blood volume, which can increase fall risk, particularly in older adults (GoodRx, 2026).
Electrolyte imbalances. Losing fluids disrupts sodium and potassium levels specifically, both of which are needed for normal heart, muscle, and nerve function (GoodRx, 2026) — this is why replacing electrolytes, not just water, matters during active fluid loss.
Worsened constipation. GLP-1 medications already slow digestion, and dehydration compounds this further (GoodRx, 2026).
Gallstones and gallbladder issues. Dehydration can make bile more concentrated, which is a contributing factor to gallstone formation (GoodRx, 2026).
Kidney stones. Lower fluid intake generally increases kidney stone risk (GoodRx, 2026).

Who faces higher risk

Certain groups should pay particular attention to hydration on a GLP-1 medication:

Older adults, whose sense of thirst and their body's ability to conserve water both naturally diminish with age — meaning the usual "drink when thirsty" approach is less reliable (GoodRx, 2026).
People with kidney disease. While GLP-1 medications may support kidney health over the longer term, fluid loss early in treatment can place extra strain on kidneys, particularly in more advanced kidney disease (GoodRx, 2026).

Electrolytes specifically — not just water

Plain water alone doesn't replace lost sodium and potassium during active fluid loss from vomiting or diarrhoea (GoodRx, 2026). Including foods that naturally contain water and electrolytes becomes especially important during these periods, and this matters more, not less, exactly when nausea or diarrhoea are already making eating harder (GoodRx, 2026).

When to contact your prescriber

Contact a healthcare provider if dehydration symptoms are severe, persistent, or you're unable to keep fluids down at all (Ro, 2026) — this crosses from a manageable side effect into something that needs direct medical attention.

Why hydration is part of the same nutrition puzzle

Hydration doesn't sit separately from everything else you're managing on a GLP-1 — it's tangled up with appetite, nausea, constipation, and fatigue, all of which either cause or are worsened by inadequate fluid and electrolyte intake. Treating it as an afterthought, rather than a deliberate daily target, is one of the more common gaps in how people approach these medications.

This is exactly the kind of practical detail our While You're On It programme is built to address — structured guidance on hydration and electrolyte intake alongside your nutrition targets, rather than leaving it to chance until symptoms show up.

If appetite loss is making it hard to get electrolytes from food, our Alongside Daily Support powder is formulated to help support both nutrient and hydration-related needs during treatment.

As you transition off treatment, our Coming Off It programme helps you carry good hydration habits forward into the maintenance phase.

And if you want your hydration and electrolyte needs reviewed alongside your specific side effect pattern, our 1:1 coaching can help you build a plan that actually fits your situation.

The bottom line

Dehydration on a GLP-1 medication is a genuine, clinically recognised risk — not just a comfort issue — because reduced thirst, lower food intake, and gastrointestinal side effects all compound to make fluid loss more likely and harder to notice. Aiming for roughly 2.7–3.7 litres of total daily water, adjusted upward during active GI symptoms, and paying specific attention to electrolytes rather than water alone, are both genuinely protective steps. Older adults and people with existing kidney disease should be especially attentive to this.

This article is for general information and isn't a substitute for medical advice. Contact your prescriber if you experience severe or persistent dehydration symptoms, or if you're unable to keep fluids down.

References

GoodRx. (2026, July 10). How much water to drink on GLP-1s: A guide to hydration. https://www.goodrx.com/classes/glp-1-agonists/how-much-water-to-drink-on-glp-1

Novo Nordisk. (2016–2024). Clinical trial protocols for semaglutide, various trials (NCT02692716, NCT03914326, NCT03136484, NCT03061214, NCT03086330, NCT03989232, NCT03191396) [Sections on acute renal impairment and dehydration]. ClinicalTrials.gov.

Ro. (2026, July 10). How much water to drink on a GLP-1: Why hydration matters. https://ro.co/weight-loss/how-much-water-to-drink-glp-1/